成都九寨沟黄龙都江堰青城山.pptVIP

WHO Staging System for HIV/AIDS in Resource Limiting Settings Unit 5 HIV Basics: A Course for Physicians earning objectives Describe how the WHo staging system is used to assist management of HIViAIdS st the clinical conditions that characterize each WHO stage of HIV/AIDS Introductory Case: Lake 33 year old male presents to art clinic for initial evaluation. He has a history of Zoster. He reports diarrhea, intermittent fever, and itching He stopped working as a merchant one month ago due to fatigue o What additional information is necessary for accurate WHo staging of this patient? Introductory Case: Lake(2) Diarrhea occurred daily, was non-bloody, and began 2 months ago Fever began 2 months ago Wt loss of 8 kg(50-42kg) over last 6 months History of PTB treatment 1 year ago No cough, night sweats Exam revealed thrush and papular rash on trunk and extremities CXR normal Stool exam normal HCT 9 g/dI WHo Staging System for H∨A|Ds: Overview Tool used to guide management of HIv patient n resource limited settings with limited aboratory access Clinically based; C D4 count not required Simple, flexible and widely used Recently revised: Interim African version 2005 Utilizes 5 clinical stages based on the degree of immunocompromise and prognosis Primary HIV Infection, I, II, WHo Staging System for HIV/AIDS: Overview(2) e Performed at each clinical visit · Diagnosis Entry to clinical care(pre-ART Follow-up Stage assessment can be adjusted upwards or downwards over time according to response to ART and/or clinical progression WHO Staging of HIVIAIDS e Primary hiv Infection Stage 1-asymptomatic Stage‖l- mild disease Stage Il-moderate disease Stage lV-advanced immunocompromise WHO Stage asymptomatic or Persistent generalized lymphadenopathy(PGL) Persistent Generalized Lymphadenopathy(PGL Courtesy of Charles Steinberg MD WHO Stage Moderate unexplained weight loss(10% of presumed or measured body weight) Recurrent respiratory tract infections(RTIs, sinusitis bronchitis,